AVEO Pharmaceuticals (NDAQ:AVEO) Rating Reconfirmed

Today, Friday, 23 June, Aveo Pharmaceuticals (NDAQ:AVEO) stock Positive was reconfirmed by Piper Jaffray in an analyst note.

NDAQ:AVEO is at the moment trading 71.75% higher at $1.25 as of 8:03 AM New York time. AVEO Pharmaceuticals’s stock is 0% in the past 200 days. It has underperformed the S&P500 Index, which has added 6.00% in the same time period.

Institutional Ownership

New Leaf Venture Partners L.L.C. had the largest stake with ownership of 2.59M shares as of q2 2015 for 1.66% of the US long stock exposure. Deer Vi & Co. Llc is another quite bullish active investment manager who is having 675,242 shares of AVEO Pharmaceuticals or 0.64% of their US long stock exposure. In addition, Nea Management Company Llc have 0.41% of their US long stock exposure invested in the company for 10.36M shares. The Connecticut-based fund Sarissa Capital Management Lp disclosed it had bought so far a stake worth about 0.41% of the active investment manager’s stock portfolio in AVEO Pharmaceuticals. The New York-based fund Perceptive Advisors Llc is also positive about the stock, possessing 2.00M shares or 0.18% of their US long stock exposure.

AVEO Pharmaceuticals (NDAQ:AVEO) Profile

AVEO Pharmaceuticals, Inc. is a biopharmaceutical company. The Company’s platform delivers insights into cancer and related disease. The Company’s product candidates include Tivozanib, Ficlatuzumab, AV-203 and AV-380.

AVEO Pharmaceuticals (NDAQ:AVEO) traded up 71.75% on 23 June, hitting $1.25. A total of 54.89 million shares of the company’s stock traded hands. This is up from average of 728,447 shares. AVEO Pharmaceuticals has a 52 week low of $0.50 and a 52 week high of $1.38. The company has a market cap of $143.49 million and a P/E ratio of 0.

Get the latest AVEO Pharmaceuticals (NDAQ:AVEO) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.

The post Professional Analysts at Piper Jaffray Kept the Same their Positive rating for AVEO Pharmaceuticals (NDAQ:AVEO) appeared first on Octafinance.